Renal oncocytoma screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m Bot: Removing from Primary care |
||
(6 intermediate revisions by 3 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Renal Oncocytoma}} | {{Renal Oncocytoma}} | ||
{{CMG}}; {{AE}}{{Homa}} {{SC}} | |||
==Overview== | |||
There is insufficient evidence to recommend routine [[Screening (medicine)|screening]] for renal oncocytoma. | |||
==Screening== | |||
There is insufficient evidence to recommend routine [[screening]] for renal oncocytoma. | |||
==References== | ==References== | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category: | |||
[[Category: | [[Category:Up-To-Date]] | ||
[[Category:Medicine]] | |||
[[Category:Oncology]] | [[Category:Oncology]] | ||
[[Category:Nephrology]] |
Latest revision as of 23:57, 29 July 2020
Renal oncocytoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Renal oncocytoma screening On the Web |
American Roentgen Ray Society Images of Renal oncocytoma screening |
Risk calculators and risk factors for Renal oncocytoma screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2] Shanshan Cen, M.D. [3]
Overview
There is insufficient evidence to recommend routine screening for renal oncocytoma.
Screening
There is insufficient evidence to recommend routine screening for renal oncocytoma.